XML 101 R83.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' DEFICIT - USD ($)
$ in Thousands
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Total
Balance as at beginning at Dec. 31, 2021         $ 382,288
Balance as at beginning (in shares) at Dec. 31, 2021         73,259,663
Increase (Decrease) in Redeemable Convertible Preferred Stock [Roll Forward]          
Accretion of Series G redeemable convertible preferred stock to redemption amount         $ 2,237
Conversion of redeemable convertible preferred stock to common stock         $ (384,525)
Conversion of redeemable convertible preferred stock to common stock (in shares)         (73,259,663)
Balance as at beginning at Dec. 31, 2021 $ 13 $ 13,682 $ (3,445) $ (498,536) $ (488,286)
Balance as at beginning (in shares) at Dec. 31, 2021 13,183,259        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Accretion of Series G redeemable convertible preferred stock to redemption amount       (2,237) (2,237)
Conversion of redeemable convertible preferred stock to common stock $ 74 384,451     384,525
Conversion of redeemable convertible preferred stock to common stock (in shares) 73,203,888        
Common stock dividends issued to Series C and Series G redeemable convertible preferred stock $ 29 (29)      
Common stock dividends issued to Series C and Series G redeemable convertible preferred stock (in shares) 28,685,582        
Issuance of common stock from option exercises $ 2 49     51
Issuance of common stock from option exercises (in shares) 2,459,014        
Issuance of common stock from conversion of convertible promissory notes and accrued interest $ 10 35,820     35,830
Issuance of common stock from conversion of convertible promissory notes and accrued interest (in shares) 10,228,522        
Stock-based compensation   17     17
Foreign currency translation adjustment     1,583   1,583
Net loss       (26,412) (26,412)
Balance as at end at Dec. 31, 2022 [1] $ 2 434,116 (1,862) (527,185) $ (94,929)
Balance as at end (in shares) at Dec. 31, 2022 23,861,000 [1]       127,760,265
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock from option exercises [1]   1     $ 1
Issuance of common stock from option exercises (in shares) [1] 5,000        
Stock-based compensation [1]   2     2
Foreign currency translation adjustment     674   674
Net loss       (1,393) (1,393)
Balance as at end at Mar. 31, 2023 [1] $ 2 434,119 (1,188) (528,578) (95,645)
Balance as at end (in shares) at Mar. 31, 2023 [1] 23,866,000        
Balance as at beginning at Dec. 31, 2022 [1] $ 2 434,116 (1,862) (527,185) $ (94,929)
Balance as at beginning (in shares) at Dec. 31, 2022 23,861,000 [1]       127,760,265
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Accretion of Series G redeemable convertible preferred stock to redemption amount         $ 0
Issuance of common stock from option exercises $ 1 22     23
Issuance of common stock from option exercises (in shares) 1,130,481        
Issuance of common stock from conversion of convertible promissory notes and accrued interest   72     72
Issuance of common stock from conversion of convertible promissory notes and accrued interest (in shares) 20,681        
Issuance of common stock from cancellation of promissory note 55,775        
Issuance of common stock from warrant exercise   1,499     1,499
Issuance of common stock from warrant exercise (in shares) 428,572        
Stock-based compensation   43     43
Foreign currency translation adjustment     324   324
Net loss       (22,469) (22,469)
Balance as at end at Dec. 31, 2023 [1] $ 3 435,752 (1,538) (549,654) $ (115,437)
Balance as at end (in shares) at Dec. 31, 2023 24,166,000 [1]       24,166,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation   1,223     $ 1,223
Foreign currency translation adjustment     1,064   1,064
Net loss       757 757
Balance as at end at Mar. 31, 2024 $ 5 $ 487,006 $ (474) $ (548,897) $ (62,360)
Balance as at end (in shares) at Mar. 31, 2024 45,833,000       45,833,000
[1] Amounts as of December 31, 2023 differ from those in prior year consolidated financial statements as they were retrospectively adjusted as a result of the accounting for the Business Combination (as defined in the Notes to the Unaudited Condensed Consolidated Financial Statements.)